Literature DB >> 7679850

Numerical chromosomal aberrations in prostate cancer: correlation with morphology and cell kinetics.

R P Henke1, E Krüger, N Ayhan, D Hübner, P Hammerer.   

Abstract

Eleven routinely processed radical prostatectomy specimens were studied for the presence of numerical chromosomal aberrations by means of in situ hybridization with nucleic acid probes specific for chromosomes 7, 10, 17, X, and Y. Cytogenetic information was correlated with morphology, tumour stage and volume as well as with cell kinetics, the latter being assessed by immunohistochemistry with antibodies raised against the proliferative cell nuclear antigen (PCNA) and against a formalin-resistant epitope of the Ki-67 antigen, MIB 1. In 5 of 11 cases, numerical aberrations of at least one chromosome were found. The cases with normal chromosome numbers were those with the smallest volumes of Gleason grade 4 and/or 5 tumour (mean 0.5 cm3) and represented tumours restricted to the prostate. Tumours with aberrations in the number of detected chromosomes showed advanced stages and large volumes of high-grade tumour (mean 12.5 cm3). All 4 tumours with positive surgical margins were recruited from a group with marked local heterogeneity in chromosome numbers. Immunostaining with MIB 1 and PCNA was most intense in areas of high-grade tumour and was positively correlated with the emergence of chromosomal aberrations. The data suggest that the appearance of numerical chromosomal aberrations in prostate cancer coincides with aggressive tumour behaviour and could be used as an additional prognostic marker.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679850     DOI: 10.1007/bf01605134

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  28 in total

1.  Cytogenetic analysis of human solid tumors by in situ hybridization with a set of 12 chromosome-specific DNA probes.

Authors:  H van Dekken; J G Pizzolo; V E Reuter; M R Melamed
Journal:  Cytogenet Cell Genet       Date:  1990

2.  Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.

Authors:  S Fukushige; K Matsubara; M Yoshida; M Sasaki; T Suzuki; K Semba; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

3.  Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84.

Authors:  T Cremer; J Landegent; A Brückner; H P Scholl; M Schardin; H D Hager; P Devilee; P Pearson; M van der Ploeg
Journal:  Hum Genet       Date:  1986-12       Impact factor: 4.132

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Correlations between atypical primary hyperplasia and carcinoma of the prostate. A histological study of 180 total prostatectomies.

Authors:  H Kastendieck
Journal:  Pathol Res Pract       Date:  1980-11       Impact factor: 3.250

6.  Human p53 gene localized to short arm of chromosome 17.

Authors:  C Miller; T Mohandas; D Wolf; M Prokocimer; V Rotter; H P Koeffler
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

7.  Chromosome rearrangements in a metastatic adenocarcinoma of the prostate.

Authors:  Z Gibas; J E Pontes; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1985-04-15

8.  Cytogenetic analysis of 57 primary prostatic adenocarcinomas.

Authors:  R Lundgren; N Mandahl; S Heim; J Limon; H Henrikson; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

9.  An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer.

Authors:  H P Schmid; J E McNeal
Journal:  Am J Surg Pathol       Date:  1992-02       Impact factor: 6.394

10.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

View more
  5 in total

1.  Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis.

Authors:  H Kawamoto; K Kawamoto; T Mizoue; T Uozumi; K Arita; K Kurisu
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

2.  Ki-67 expression in early prostate cancer and associated pathological lesions.

Authors:  M R Feneley; M P Young; C Chinyama; R S Kirby; M C Parkinson
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

3.  Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.

Authors:  T Visakorpi; E Hyytinen; A Kallioniemi; J Isola; O P Kallioniemi
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

4.  Analysis of the growth rate and cavernous sinus invasion of pituitary adenomas.

Authors:  H Kawamoto; T Uozumi; K Kawamoto; K Arita; T Yano; T Hirohata
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 5.  Molecular and genetic prognostic factors of prostate cancer.

Authors:  Arnab Chakravarti; Gary Guotang Zhai
Journal:  World J Urol       Date:  2003-08-09       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.